CLINICAL_TRIALS
research
· 2026-04-09
Clinical Trial Update: A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations [Phase 3]
Summary
A Phase 3 study is exploring whether a fixed-dose combination inhaler of fluticasone propionate and albuterol sulfate can prevent asthma exacerbations; the tria…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Asthma | Phase 3 | Status: RECRUITING